Deferred Tax Assets, Valuation Allowance of CITIUS ONCOLOGY, INC. from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: CITIUS ONCOLOGY, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2023 to 30 Sep 2025.
CITIUS ONCOLOGY, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2025 was $19,418,000, a 65% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

CITIUS ONCOLOGY, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$19,418,000	+$7,682,000	+65%	30 Sep 2025	10-K	23 Dec 2025	2025	FY
Q3 2024	$11,736,000	+$7,693,000	+190%	30 Sep 2024	10-K	23 Dec 2025	2025	FY
Q3 2023	$4,043,000			30 Sep 2023	10-K	27 Dec 2024	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.